Popular Articles

Current Status Of The Development Programs Of New Indications And Formulations For Aricept(R) For Enhancing Patient Value
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") and Eisai Corporation of North America (Headquarters: Woodcliff Lake, NJ, Chairman and CEO Hajime Shimizu) are currently focusing on three clinical development programs for the company"s major product Aricept(R) (donepezil hydrochloride tablets) to further contribute to patients with Alzheimer"s disease. As progress in those programs has been made, Eisai announces the status as follows:

'Nutrition Agenda 2009' Is Focus Of Fourth Tufts Friedman School Symposium
First year to be offered live and online
News of the day
Questioning The Credibility Of Some Published Clinical Trials
Randomised Controlled Trials (RCTs) are considered the "gold standard" research method for assessing new medical treatments. But research published in BioMed Central"s open access journal Trials shows that the design of a remarkable 93 percent of 2235 so-called RCTs published in some Chinese medical journals during 1994 to 2005 was flawed, casting doubt on the reliability of research that is likely to influence medical decision-makers.
Health Insurance

APhA Seeks Nominations For Scientific Awards And Honors

The American Pharmacists Association (APhA), the national professional society of pharmacists, announces that nominations are now being accepted for the APhA scientific awards and honors that will be presented at the APhA Annual Meeting and Exposition in Washington, DC, March 12-15, 2010. Nominations must be received at APhA headquarters by September 15, 2009. APhA"s awards recognition program is American pharmacy"s most comprehensive recognition program. Guidelines for nominations, the nomination form, and complete criteria for each award are available at www.pharmacist.com/awards. Please submit all nomination materials to: APhA Awards and Honors Program- Attention: Meredith Nelson, 2215 Constitution Avenue, NW, Washington, DC 20037-2985, or email to mnelson@aphanet.org. Nominator and support signatures are required on all letters. Please indicate which awards or honors you wish to make a nomination. For additional questions please contact Meredith Nelson at (202) 429-7559. Awards Takeru Higuchi Research Prize: The award, established in 1981 in honor of Dr. Takeru Higuchi, the first president of the APhA Academy of Pharmaceutical Sciences, recognizes the highest accomplishments in pharmaceutical sciences, and is international in scope and stature. Scientists selected to receive the award shall have demonstrated effective and persistent efforts in pioneering a new concept applicable to the pharmaceutical sciences. Recipients must be an APhA member. Research Achievement Award in the Pharmaceutical Sciences: The award, offered annually and rotated every year among the three APhA Academy of Pharmaceutical Research and Science (APhA-APRS) Sections, is intended to recognize and encourage outstanding, meritorious achievement in any of the pharmaceutical sciences. In 2010, the award will recognize contributions in the area of basic pharmaceutical sciences. Nominees do not have to be members of APhA-APRS, but must be an APhA member. APhA Fellow: This honor recognizes APhA members with a minimum of 10 years of exemplary professional experience and achievements in professional practice, who have rendered outstanding service to the profession through activities in APhA and in other organizations. Examples of service to organizations may include having held an elected or appointed office, service on a committee, expert panel or review board, or other relevant activities. The selection of Fellows is done by the respective academies, with APhA-APRS presenting up to 10 Fellow designations each year. Wiederholt Prize: Established in 1996 as the Best Published Paper Award in Social, Economic and Administrative Sciences and renamed in 2002 as the Wiederholt Prize, this award, presented annually, recognizes the best-published paper describing original investigation in the area of economic, social, or administrative sciences related to pharmacy. The paper must have been published in the Journal of the American Pharmacists Association (JAPhA) within the last two calendar years and the primary author must be an APhA member. Ebert Prize: Established in 1873, the Ebert Prize is the oldest pharmacy award in existence in the United States. This award recognizes the author(s) of the best essay or written communication containing original investigation of a medicinal substance published in the Journal of Pharmaceutical Sciences in the past year. The paper selected must have been published during the calendar year preceding the selection. Awardees need not be members of APhA for consideration. Clinical Research Paper Award: The award, established in 2006, is intended to promote and encourage high quality clinical research or practice based research in the clinical sciences by recognizing an original research article in this area, which has been published in the JAPhA within two years prior to the screening deadline. The primary author (first and/or corresponding author) must be a member of APhA. American Pharmacists Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):